PRKCI and ovarian carcinoma: With the aid of both in vitro and in vivo experimental models, we showed that an EpCAM aptamer and PKCι siRNA chimera (EpCAM-siPKCι aptamer) not only induced apoptosis in PRKCI-amplified ovarian cancer cells but also suppressed intraperitoneal ovary tumor development.